IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 223 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $584,862 | +129.9% | 128,541 | +208.8% | 0.00% | 0.0% |
Q1 2023 | $254,372 | -92.8% | 41,632 | -88.7% | 0.00% | -94.4% |
Q3 2022 | $3,528,000 | +882.7% | 368,310 | +1609.4% | 0.02% | +800.0% |
Q1 2022 | $359,000 | -84.8% | 21,546 | -82.6% | 0.00% | -66.7% |
Q4 2021 | $2,359,000 | +128.1% | 123,591 | +194.5% | 0.01% | +100.0% |
Q3 2021 | $1,034,000 | +23.2% | 41,961 | +30.2% | 0.00% | 0.0% |
Q2 2021 | $839,000 | -41.5% | 32,234 | -28.9% | 0.00% | -66.7% |
Q1 2021 | $1,435,000 | +245.0% | 45,327 | +258.6% | 0.01% | +50.0% |
Q3 2020 | $416,000 | -88.5% | 12,640 | -90.4% | 0.01% | -89.8% |
Q2 2020 | $3,617,000 | +1673.0% | 131,770 | +1834.9% | 0.06% | +1080.0% |
Q1 2020 | $204,000 | -85.4% | 6,810 | -86.5% | 0.01% | -37.5% |
Q4 2019 | $1,393,000 | +120.4% | 50,320 | +44.9% | 0.01% | +33.3% |
Q3 2019 | $632,000 | -52.7% | 34,728 | -36.3% | 0.01% | -53.8% |
Q2 2019 | $1,337,000 | -58.2% | 54,515 | -83.8% | 0.01% | -61.8% |
Q1 2019 | $3,201,000 | +67.1% | 336,627 | +55.5% | 0.03% | +54.5% |
Q4 2018 | $1,916,000 | -32.7% | 216,452 | -14.4% | 0.02% | -35.3% |
Q3 2018 | $2,846,000 | +54.4% | 253,000 | +75.7% | 0.03% | +41.7% |
Q2 2018 | $1,843,000 | +2.4% | 144,000 | +35.2% | 0.02% | -17.2% |
Q1 2018 | $1,800,000 | +1507.1% | 106,500 | +663.7% | 0.03% | +1350.0% |
Q4 2017 | $112,000 | -66.6% | 13,946 | -67.7% | 0.00% | -66.7% |
Q3 2017 | $335,000 | – | 43,206 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |